News

Researchers have discovered a drug target in glioblastoma cells that could potentially undermine both these sources of resistance.

Scientists at Johns Hopkins Medicine say a study that sequenced human cancers found far fewer microbial DNA sequences than earlier studies reported in the same cancer tissue samples.

The grant competition attracted 3,928 proposals, marking a 13% increase in demand from 2024’s opening call.

When detached cancer cells squeeze through the tiniest blood vessels, they can become prone to grow new tumors far from where they started, a blood flow simulation experiment suggests.

Spaceflight triggers genetic, mitochondrial and inflammatory stress in blood-forming stem cells, shedding light on aging and disease risks in long missions.

Researchers trace how chemicals from cigarettes and other environmental toxins lead to higher risk of pancreatic cancer and worse outcomes.

Polyamines are natural molecules that support cell health and have been linked to longer lifespans. Yet, they also appear in high levels in many cancers. The research reveals new treatment opportunities.

Researchers from the University of Michigan tracked how glucose is used in glioblastoma tumor cells.

Triple-negative breast cancer is particularly aggressive and difficult to treat, but recent research may offer a new way to target the often-deadly disease.

Researchers have created a protein-based therapeutic tool that could change the way we treat diseases caused by harmful or unnecessary cells by offering targeted removal.